DiaMedica Therapeutics Inc. Common Stock
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
DMAC Key Statistics
Stock Snapshot
As of today, DiaMedica Therapeutics Inc. Common Stock(DMAC) shares are valued at $5.93. The company's market cap stands at 319.53M, with a P/E ratio of -8.59.
On 2026-05-18, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock moved within a range of $5.90 to $6.12. With shares now at $5.93, the stock is trading +0.5% above its intraday low and -3.1% below the session's peak.
Trading volume for DiaMedica Therapeutics Inc. Common Stock(DMAC) stock has reached 35.27K, versus its average volume of 177.28K.
The stock's 52-week range extends from a low of $3.48 to a high of $10.42.
The stock's 52-week range extends from a low of $3.48 to a high of $10.42.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.